Telehealth And Home Healthcare Will Redefine Pain Management
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
19 May 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$3.70
57.0% undervalued intrinsic discount15 Aug
US$1.59
1Y
-78.7%7D
8.2%